3D Printing of Biomaterials: Is It Disruptive or Destructive?

3D printing represents a new era in the field of digital manufacturing, finding its applications in many industries, such as healthcare, automotive, and aerospace. In particular, 3D printing has the potential to completely revolutionize the manufacturing process for implants, medical equipment, and even human tissues within the healthcare industry. The rapid rise of 3D printing raises fundamental questions i.e., Is this technology truly revolutionary, or does it perhaps take us in a direction other than we might expect? This editorial aim to consider the dual-edged nature of 3D printing, with particular respect to biomaterials, and argue for a more selective and responsible approach in using it. Furthermore, the importance of regulatory frameworks in ensuring the safety and effectiveness of 3D printing for healthcare applications cannot be overlooked. While such frameworks are well-established in the EU, UK, and USA, they are notably absent in the MENA region.